Abstract
P1-275: Very elderly NSCLC patients above 75 years: Response to chemotherapy and improvement in Quality of Life is achievable to the same extent as for younger patients during platinum-based doublet chemotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have